Written question asked by Virendra Sharma (Labour) on Monday, 14 December 2015, in the House of Commons. It was due for an answer on Wednesday, 16 December 2015. It was answered by George Freeman (Conservative) on Friday, 18 December 2015 on behalf of the Department of Health.
NHS: Drugs
- Question
-
To ask the Secretary of State for Health, pursuant to the Answer of 23 November 2015 to Question 16399, what discussions he has had with the Accelerated Access Review team on biosimilars medicines; and whether he has been given assurance that the final report will make specific recommendations on their use.
- Answer
-
In accordance with the terms of reference the Accelerated Access Review is not excluding any particular type or class of medicine, but is creating a framework through which to accelerate access for National Health Service patients to innovative health technologies including biosimilar medicines where appropriate.
Secondary information
- Type
- Written question
- Reference
- 20066
- Session
- 2015-16
- Related items
- Grouped for answer
- Yes
- Subjects
- Drugs NHS
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2023-01-27 14:47:43 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2015-16/20066
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2015-16/20066
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2015-16/20066